Related references
Note: Only part of the references are listed.Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2
Mohamed A. Morsy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats
Misbahuddin Rafeeq et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2021)
AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis
Siddharth Singh et al.
GASTROENTEROLOGY (2020)
Microemulsion Microstructure(s): A Tutorial Review
Giuseppe Tartaro et al.
NANOMATERIALS (2020)
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways
Alla Zamyatina et al.
FRONTIERS IN IMMUNOLOGY (2020)
Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection
Kathryn Burge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder
Manu Sharma et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats
Gulcin Ercan et al.
ACTA CIRURGICA BRASILEIRA (2019)
Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease
Jiulong Zhao et al.
THERANOSTICS (2019)
Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders
Peter Szatmary et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Microemulsion systems containing bioactive natural oils: an overview on the state of the art
F. H. Xavier-junior et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles
Ornchuma Naksuriya et al.
AAPS JOURNAL (2016)
DLS and zeta potential - What they are and what they are not?
Sourav Bhattacharjee
JOURNAL OF CONTROLLED RELEASE (2016)
New Trends on Antineoplastic Therapy Research: Bullfrog (Rana catesbeiana Shaw) Oil Nanostructured Systems
Lucas Amaral-Machado et al.
MOLECULES (2016)
PARADOXICAL ROLES OF ANTIOXIDANT ENZYMES: BASIC MECHANISMS AND HEALTH IMPLICATIONS
Xin Gen Lei et al.
PHYSIOLOGICAL REVIEWS (2016)
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
Bo Xiao et al.
THERANOSTICS (2016)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Role of extracellular histones in the cardiomyopathy of sepsis
Miriam Kalbitz et al.
FASEB JOURNAL (2015)
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Sufeng Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Sara Renna et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Curcumin, a component of turmeric: From farm to pharmacy
Subash C. Gupta et al.
BIOFACTORS (2013)
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
Marte Lie Hoivik et al.
GUT (2013)
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Kang-Moon Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin
Mehmet H. Ucisik et al.
JOURNAL OF NANOBIOTECHNOLOGY (2013)
Conundrum and Therapeutic Potential of Curcumin in Drug Delivery
Anil Kumar et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Luigi Battaglia et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Nanoemulsions versus microemulsions: terminology, differences, and similarities
David Julian McClements
SOFT MATTER (2012)
The Targets of Curcumin
Hongyu Zhou et al.
CURRENT DRUG TARGETS (2011)
Multitargeting by curcumin as revealed by molecular interaction studies
Subash C. Gupta et al.
NATURAL PRODUCT REPORTS (2011)
Terminology of polymers and polymerization processes in dispersed systems (IUPAC Recommendations 2011)
Stanislaw Slomkowski et al.
PURE AND APPLIED CHEMISTRY (2011)
Bioactive Food Components, Inflammatory Targets, and Cancer Prevention
Young S. Kim et al.
CANCER PREVENTION RESEARCH (2009)
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
Bharat B. Aggarwal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Improving the solubility and pharmacological efficacy of curcumin by heat treatment
Biji T. Kurien et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause?
Ali Rezaie et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Medical therapy for ulcerative colitis 2004
SB Hanauer
GASTROENTEROLOGY (2004)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Share Paper
